// App-Quantinova.ai

e21624 : Adverse events associated with checkpoint and signal transduction inhibitors in unselected survivors with metastatic melanoma.

Researchers

Presenter

  • Taryn A Gitter

Principal Investigators

  • Leo Chen

  • Winson Y. Cheung

Medical Centers

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved